The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 2, Pages -
Publisher
Springer Nature
Online
2018-02-07
DOI
10.1038/s41419-017-0247-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
- (2018) Noah Isakov SEMINARS IN CANCER BIOLOGY
- The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies
- (2016) Daniel Martinez Molina et al. Annual Review of Pharmacology and Toxicology
- Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway
- (2016) Yan Liu et al. APOPTOSIS
- Sinularin Induces Apoptosis through Mitochondria Dysfunction and Inactivation of the pI3K/Akt/mTOR Pathway in Gastric Carcinoma Cells
- (2016) Yu-Jen Wu et al. Marine Drugs
- Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo
- (2016) Chin-Cheng Su et al. ONCOLOGY REPORTS
- Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling
- (2016) Na Guo et al. PLoS One
- Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C
- (2016) Suthakar Ganapathy et al. Oncotarget
- Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma
- (2016) Matthew H. Wong et al. NEOPLASIA
- Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer
- (2015) Radha Munagala et al. CANCER LETTERS
- Treatment of Obesity with Celastrol
- (2015) Junli Liu et al. CELL
- Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells
- (2015) Dan Zi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Proteomics Analysis of Cellular Proteins Co-Immunoprecipitated with Nucleoprotein of Influenza A Virus (H7N9)
- (2015) Ningning Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells
- (2015) RYOSUKE HORIE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
- (2014) Komal Jhaveri et al. Clinical Breast Cancer
- Potential Therapeutic Roles of Tanshinone IIA in Human Bladder Cancer Cells
- (2014) Sheng-Chun Chiu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protein kinase C and cancer: what we know and what we do not
- (2013) R Garg et al. ONCOGENE
- Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo
- (2013) S C Chiu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Guidelines for the use and interpretation of assays for monitoring autophagy
- (2012) Daniel J. Klionsky et al. Autophagy
- Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
- (2012) L. Whitesell et al. CURRENT MOLECULAR MEDICINE
- Applications of Connectivity Map in drug discovery and development
- (2012) Xiaoyan A. Qu et al. DRUG DISCOVERY TODAY
- Protein kinase C, an elusive therapeutic target?
- (2012) Daria Mochly-Rosen et al. NATURE REVIEWS DRUG DISCOVERY
- HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
- (2011) S. Modi et al. CLINICAL CANCER RESEARCH
- Contribution of individual PKC isoforms to breast cancer progression
- (2011) Alejandro J. Urtreger et al. IUBMB LIFE
- Fine Tuning of Protein Kinase C (PKC) Isoforms in Cancer: Shortening the Distance from the Laboratory to the Bedside
- (2011) R. Bosco et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map
- (2011) Zhining Wen et al. PLoS One
- Tanshinone IIA Induces Mitochondria Dependent Apoptosis in Prostate Cancer Cells in Association with an Inhibition of Phosphoinositide 3-Kinase/AKT Pathway
- (2010) Suk-Hyun Won et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- PKCα expression is a marker for breast cancer aggressiveness
- (2010) Gry Lønne et al. Molecular Cancer
- Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells
- (2009) Yun-feng Shan et al. ACTA PHARMACOLOGICA SINICA
- Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras
- (2009) T Zhu et al. ONCOGENE
- Natural compounds for cancer treatment and prevention
- (2009) Stefania Nobili et al. PHARMACOLOGICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now